Back

Resistant pulmonary effusion as a marker of amyloid disease.

26 August 2022 (11:48 - 12:01)
Organised by:
Congress Presentation Part of: Heart failure-challenges in workup Cardio-Oncology ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Nataliia Dovganych

Strazhensku Cardiology Institute, Kiev (Ukraine)

4 More presentations in this session

Presentation thumbnail
Heart failure-challenges in work-up - Get ready for the session.
Slides Video
Presentation thumbnail
A 59-year-old man with dyspnoea and eosinophilia.
Mr K. Jakobs (Berlin, DE)
Slides Video
Presentation thumbnail
Left ventricular noncompaction, a puzzling link of different genotypes and phenotypes: a case report.
Mr L. Santos (Porto, PT)
Slides Video
Presentation thumbnail
A rare cause of heart failure
Doctor F. Al-Moosa (London, GB)
Slides Video

Access the full session

Session thumbnail
Heart failure-challenges in workup
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 11:48 CET
You may be interested in
thumbnail
Congress Presentation
Exploring ATTR cardiomyopathy: the journey to improved outcomes
thumbnail
Congress Presentation
Evolving the understanding of TTR's role in health and disease​
thumbnail
Congress Presentation
Rapid stiffening as a loud warning: a case of light-chain cardiac amyloidosis presenting with isolated diastolic collapse

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources